EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Gut Microbiota and Liver Health: Meta-Analysis of Bifidobacterium-Containing Probiotics in NAFLD Management

Ko-Shih Chang, Wu-Hsien Kuo, Mu-Hsin Chang, Yao Hsiao, Ru-Yin Tsai iD

International Journal of Molecular Sciences · 20.06.2025 · 26 (13) · 5944

DOI: 10.3390/ijms26135944 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.06.2025. Verfasst von Ko-Shih Chang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Yuan Rung Hospital, Yuanlin, Changhua 51045, Taiwan. Hauptthemen laut MEDLINE: Probiotics, Non-alcoholic Fatty Liver Disease, Bifidobacterium, Gastrointestinal Microbiome. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chung Shan Medical University-Yuan-Rung Hospital Research Collaboration.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diseases, including cardiovascular disease, type II diabetes, and metabolic syndrome, are leading causes of morbidity and mortality worldwide. Non-alcoholic fatty liver disease (NAFLD) is commonly associated with these conditions through shared pathophysiological mechanisms such as insulin resistance, chronic inflammation, and dyslipidemia. Emerging evidence suggests that probiotic formulations containing Bifidobacterium species may support cardiometabolic health by modulating gut microbiota composition. This meta-analysis aimed to assess the efficacy of Bifidobacterium-containing probiotic combinations in improving key cardiometabolic parameters, including lipid profiles, blood pressure, glycemic indices, and inflammatory biomarkers among individuals with NAFLD. A systematic literature search was conducted across PubMed, Embase, the Cochrane Library, and Web of Science databases to identify relevant randomized controlled trials (RCTs) published up to December 2024. A total of 24 RCTs involving 1611 participants met the inclusion criteria. The pooled results demonstrated significant reductions in total cholesterol, triglycerides, and low-density lipoprotein cholesterol following probiotic intervention. Improvements were also observed in fasting glucose levels and inflammatory markers, including high-sensitivity C-reactive protein (hs-CRP), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6). Although modest improvements were noted in NAFLD severity, the effects on liver injury markers were relatively limited. These findings suggest that Bifidobacterium-based probiotic combinations may provide cardiometabolic benefits, particularly in lipid regulation, glucose metabolism, and inflammatory control. Further large-scale, well-designed RCTs are warranted to validate these results and to determine the most effective probiotic strains, compositions, and treatment durations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsNon-alcoholic Fatty Liver DiseaseBifidobacteriumGastrointestinal MicrobiomeLiverHumansBiomarkers

Stichwörter der Autor:innen

body mass indexcytokineinflammationlipidprebiotic

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Cardiology, Yuan Rung Hospital, Yuanlin, Changhua 51045, Taiwan.
  • Department of Gastroenterology and Hepatology, Yuan Sheng Branch, Yuan-Rung Hospital, Changhua 51052, Taiwan.
  • Division of Cardiovascular Medicine, Yuan Rung Hospital, Yuanlin, Chenghua 51045, Taiwan.
  • School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.
  • Department of Anatomy, School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.
  • Department of Medical Education, Chung Shan Medical University Hospital, Taichung 40201, Taiwan.

ORCID-Profile: Ru-Yin Tsai

Förderung

  • Chung Shan Medical University-Yuan-Rung Hospital Research Collaboration

Zitieren

APA

Chang, K. S., Kuo, W. H., Chang, M. H., Hsiao, Y., & Tsai, R. Y. (2025). Gut Microbiota and Liver Health: Meta-Analysis of Bifidobacterium-Containing Probiotics in NAFLD Management. International Journal of Molecular Sciences, 26(13), 5944. https://doi.org/10.3390/ijms26135944

Vancouver

Chang KS, Kuo WH, Chang MH, Hsiao Y, Tsai RY. Gut Microbiota and Liver Health: Meta-Analysis of Bifidobacterium-Containing Probiotics in NAFLD Management. International Journal of Molecular Sciences. 2025;26(13):5944. doi:10.3390/ijms26135944

BibTeX
@article{Chang2025,
  author = {Chang, Ko-Shih and Kuo, Wu-Hsien and Chang, Mu-Hsin and Hsiao, Yao and Tsai, Ru-Yin},
  title = {Gut Microbiota and Liver Health: Meta-Analysis of Bifidobacterium-Containing Probiotics in NAFLD Management},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {13},
  pages = {5944},
  doi = {10.3390/ijms26135944}
}
Kostenlos starten →